Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIAsp-3858 in insulin-naive adults with type 2 diabetes mellitus
IRCT201104266297N1Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2011; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201104266297N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201104266297N1.